Collagen-Based Matrices for Osteoconduction: A Preclinical In Vivo Study

Current knowledge on bone graft substitutes remains incomplete, particularly regarding the role of mineralization and membrane coverage in osteoconductive scaffolds. Prior research has shown that collagen-based matrices support bone regeneration but do not fully replicate natural bone formation. No prior work had resolved the specific impact of hydroxyapatite addition or membrane placement on defect healing. This gap motivated the need for a controlled in vivo study to clarify these variables. The study aimed to address uncertainty in how mineralization and barrier membranes influence bone density and volume. Researchers sought to determine whether these factors could enhance osteoconduction in critical size defects. Previous findings suggested that woven bone often forms in defect centers, but the role of scaffold composition is unclear. This study aimed to test whether mineralization or membrane coverage could improve outcomes.

The study aimed to assess the effect of hydroxyapatite addition and membrane placement on bone regeneration in calvarial defects. Researchers focused on how these variables influence bone density, volume, and defect closure. The motivation was to clarify whether mineralization or membrane coverage enhances osteoconductive properties. The primary question was whether mineralized collagen matrices outperform non-mineralized ones. The study also aimed to determine if membrane coverage improves healing outcomes. The researchers tested whether mineralization or membranes could increase bone height or density. The goal was to evaluate these factors in a controlled in vivo model. The study sought to provide evidence for optimal scaffold design in bone regeneration.

The study used a randomized controlled design in a rabbit calvarial model. Critical size defects were created in 16 New Zealand White Rabbits. Animals were divided into groups based on matrix type and membrane coverage. Half received collagen-based matrices (CM), and half received mineralized collagen matrices (mCM). Half of the sites were covered with a collagen membrane. Healing was assessed after 12 weeks of recovery. Micro-CT and histology were used to evaluate bone formation. The study focused on bone density, volume, and defect closure. Researchers compared outcomes between CM and mCM with and without membranes.

Newly formed lamellar bone was observed at the periphery of all defects. In central areas, woven and lamellar bone were embedded in soft tissue. mCM samples showed more residual biomaterial than CM samples. mCM also induced more small bony islands in the central defect areas. Membrane placement decreased bone density and height in the central region. No complete defect closure was observed in any group at 12 weeks. Significant differences were found only in bone height for CM with and without membranes. Neither mineralization nor membrane placement improved overall osteogenic capacity. Bone density was influenced by mineralization in the absence of membranes. Bone volume was affected by mineralization under membrane coverage.

The authors propose that mineralization and membrane placement do not enhance osteogenic capacity in this model. They suggest that CM may be used as a scaffold without membrane coverage. Mineralization influenced bone density in the absence of a membrane. Bone volume was affected by mineralization under membrane coverage. The study found no evidence that mCM or membranes improve defect closure. The researchers propose that CM alone supports bone regeneration in this context. The findings suggest that membrane placement may reduce bone density and height. Further preclinical studies are needed to optimize mCM potential, as proposed by the authors.